Molecular Signature of Monocytes Shaped by the Shigella sonnei 1790-Generalized Modules for Membrane Antigens Vaccine

Author:

Tondi Serena12,Siena Emilio1,Essaghir Ahmed1,Bozzetti Benoît3,Bechtold Viviane3,Scaillet Aline3,Clemente Bruna1,Marrocco Mariateresa12,Sammicheli Chiara1,Tavarini Simona1,Micoli Francesca4,Oldrini Davide4ORCID,Pezzicoli Alfredo1,Di Fede Martina1,Brazzoli Michela1,Ulivieri Cristina2ORCID,Schiavetti Francesca1

Affiliation:

1. Preclinical Research & Development, GSK, 53100 Siena, Italy

2. Department of Life Sciences, University of Siena, 53100 Siena, Italy

3. Preclinical Research & Development, GSK, 1330 Rixensart, Belgium

4. GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy

Abstract

Shigellosis, an acute gastroenteritis infection caused by Shigella species, remains a public health burden in developing countries. Recently, many outbreaks due to Shigella sonnei multidrug-resistant strains have been reported in high-income countries, and the lack of an effective vaccine represents a major hurdle to counteract this bacterial pathogen. Vaccine candidates against Shigella sonnei are under clinical development, including a Generalized Modules for Membrane Antigens (GMMA)-based vaccine. The mechanisms by which GMMA-based vaccines interact and activate human immune cells remain elusive. Our previous study provided the first evidence that both adaptive and innate immune cells are targeted and functionally shaped by the GMMA-based vaccine. Here, flow cytometry and confocal microscopy analysis allowed us to identify monocytes as the main target population interacting with the S. sonnei 1790-GMMA vaccine on human peripheral blood. In addition, transcriptomic analysis of this cell population revealed a molecular signature induced by 1790-GMMA mostly correlated with the inflammatory response and cytokine-induced processes. This also impacts the expression of genes associated with macrophages’ differentiation and T cell regulation, suggesting a dual function for this vaccine platform both as an antigen carrier and as a regulator of immune cell activation and differentiation.

Funder

GlaxoSmithKline Biologicals SA

GSK

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference59 articles.

1. Evaluation of Molecular Serotyping Assays for Shigella Flexneri Directly on Stool Samples;Liu;J. Clin. Microbiol.,2021

2. Picking, W.D., Viswanathan, V.K., Mariane, S., Fleiszig, J., Marteyn, B.S., Anderson, M., and Sansonetti, P.J. (2016). Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century. Front. Cell. Infect. Microbiol., 1.

3. In Silico Serotyping Based on Whole-Genome Sequencing Improves the Accuracy of Shigella Identification;Wu;Appl. Environ. Microbiol.,2019

4. Akhondi, H., and Simonsen, K.A. (2019). StatPearls, StatPearls Publishing.

5. Differences among Shigella spp. in Susceptibility to the Bactericidal Activity of Human Serum;Okamura;Microbiology,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3